Cargando…
Butyrate inhibits Staphylococcus aureus-aggravated dermal IL-33 expression and skin inflammation through histone deacetylase inhibition
Atopic dermatitis (AD) is an inflammatory skin disease caused by the disruption of skin barrier, and is dominated by the type 2 immune responses. Patients with AD have a high risk of developing Staphylococcus aureus infection. Interleukin-33 (IL-33), an alarmin, has been implicated in the pathophysi...
Autores principales: | Luo, Chia-Hui, Lai, Alan Chuan-Ying, Chang, Ya-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228744/ https://www.ncbi.nlm.nih.gov/pubmed/37261337 http://dx.doi.org/10.3389/fimmu.2023.1114699 |
Ejemplares similares
-
Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012) -
Inhibition of Histone Deacetylase by Butyrate Protects Rat Liver from Ischemic Reperfusion Injury
por: Sun, Jie, et al.
Publicado: (2014) -
Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases
por: Han, Anna, et al.
Publicado: (2018) -
Sodium Butyrate Stimulates Expression of Fibroblast Growth Factor 21 in Liver by Inhibition of Histone Deacetylase 3
por: Li, Huating, et al.
Publicado: (2012) -
Butyrate potentiates Enterococcus faecalis lipoteichoic acid-induced inflammasome activation via histone deacetylase inhibition
por: Park, Ok-Jin, et al.
Publicado: (2023)